Analysed PALISADE BIO INC (PALI:NASDAQ) News Sources
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11-06-2026
yahoo.com
PALI Stock Heads For Best Day In Seven Months – What’s Driving Today’s Rally?
29-06-2026
stocktwits.com
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
21-09-2026
yahoo.com
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
22-09-2026
yahoo.com
Palisade Bio Advances PALI-2108 Into Phase II for Ulcerative Colitis and Crohn’s
27-09-2026
marketbeat.com
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
28-09-2026
yahoo.com
Palisade Bio Presents New Clinical, Pharmacokinetic, Pharmacodynamic and Mechanistic Data Strengthening the Phase 2 Rationale for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at ACG 2026
12-10-2026
yahoo.com
What is the current price of PALISADE BIO INC (PALI:NASDAQ)?
The current price of PALISADE BIO INC (PALI:NASDAQ) is $1.23.
PALISADE BIO INC (PALI:NASDAQ) absolute price change since previous trading day?
The absolute price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is $-0.1.
PALISADE BIO INC (PALI:NASDAQ) percentage price change since previous trading day?
The percentage price change of PALISADE BIO INC (PALI:NASDAQ) since the previous trading day is -7.5188%.
What is the most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ)?
The most recent average sentiment score for PALISADE BIO INC (PALI:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for PALISADE BIO INC (PALI:NASDAQ)?
The most recent sentiment for PALISADE BIO INC (PALI:NASDAQ) is .
SEC-8K** Filing Available For PALISADE BIO INC (PALI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.